相关实验视频

Updated: Jun 11, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

设计,合成,对接研究和生物活动的新型类似的环胺作为潜在的抗癌剂

Khodayar Gholivand¹, Soobieh Alemi Rostami¹, Marzie Sabaghian¹

¹Department of Chemistry, Faculty of Science, Tarbiat Modares University, P.O. Box 14115-175, Tehran, Iran.

Current medicinal chemistry

|October 8, 2024

概括

研究人员为乳腺癌治疗合成了新型环胺类类似物. 两种化合物对MCF-7细胞表现出显著的抗癌活性,具有有前途的in silico和in vitro结果.

科学领域:

药用化学医学化学
有机合成有机合成
癌症研究癌症研究

背景情况:

环胺是广泛使用的化疗药物.
开发新的类似物对于提高疗效和减少副作用至关重要.
乳腺癌仍然是一个重大的全球健康挑战.

研究的目的:

合成和描述新型环胺类同类物.
评估这些化合物对乳腺癌细胞 (MCF-7) 的体外抗癌活性.
评估化合物对正常细胞 (HUVEC) 的影响,并探索它们的作用机制.

主要方法:

四种新型环胺类同类物及其前体的合成和结构阐明.
针对MCF-7和HUVEC细胞系的体外细胞毒性测定 (IC50测定).
素V/PI染色,ROS测定,以及在研究 (DFT-D优化,虚拟对接).

主要成果:

两种合成的类似物,2-(bis(2-chloroethyl) amino) -1,3,2-diazaphospholidine 2-oxide (2) 和2-(bis(2-hydroxyethyl) amino) -1,3,2-diazaphospholidine 2-oxide (7),对MCF-7细胞表现出显著的度依赖的细胞毒性 (IC50值分别为8.98微米和28.74微米).
测试表明细胞活力降低和线粒体功能障碍.
与环胺相比,in silico研究显示了某些化合物与B-DNA和STAT3受体的增强相互作用.

结论:

新型环胺类类似物对乳腺癌具有有前途的抗癌潜力.
在和体外发现支持这些化合物的疗效.
需要进一步的研究来探索它们的治疗应用.

关键词:

环酸胺的使用方法在MTT测试中使用MTT测试.这是一种抗癌药物.乳腺癌乳腺癌乳腺癌对接研究.

更多相关视频

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...